MTOR and chronic myelogenous leukemia, BCR-ABL1 positive: Only one study showed that in CML, PLC-γ1 involved in leukemogenesis via a novel Akt-independent, PLC-γ1-driven mechanism of activation of mTOR/p70S6-K [30].